Results 21 to 30 of about 41,286 (251)

Optimal management of giant cell arteritis and polymyalgia rheumatica [PDF]

open access: yes, 2012
Rodger CharltonCollege of Medicine, Swansea University, Wales, UKAbstract: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are clinical diagnoses without "gold standard" serological or histological tests, excluding temporal ...
Rodger Charlton, Charlton R
core   +1 more source

Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure [PDF]

open access: yes, 2023
Giant Cell Arteritis (GCA) is the commonest form of systemic vasculitis in people over the age of 50. Published research highlighted the lack of a disease-specific patient reported outcomes (PROMs) for GCA.
El Miedany, Y.   +10 more
core   +1 more source

Temporal arteritis [PDF]

open access: yesNeurology Clinical Practice, 2014
Temporal or giant cell arteritis is an inflammation of medium and small extracranial vessels that may result in ocular ischemia, an aortitis followed by aortic dissection and peripheral limb ischemia. It should be considered a medical emergency due to the seriousness of end organ damage, in particular visual symptoms.
Andrew W, Lee   +2 more
openaire   +2 more sources

High-output cardiac failure due to multiple femoral arteriovenous fistulae

open access: yesThe Pan African Medical Journal, 2020
A 39-year-old woman presented with symptoms of dyspnea, orthopnea, paroxysmal nocturnal dyspnea, weight loss, night sweats and fatigue that were present for 3-months.
Mogamat-Yazied Chothia, Amaan Panday
doaj   +1 more source

Outcomes of segmental femoral artery pseudoaneurysm in patients with Behçet’s disease: a single center’s experience [PDF]

open access: yesJornal Vascular Brasileiro, 2019
Background Behçet's disease (BD) is an autoimmune condition that involves multiple systems. The most common arterial manifestation in BD patients is pseudoaneurysm, which has higher frequency than aneurysm formation. Objectives To clarify the importance
Hussein Mahmoud Khairy   +1 more
doaj   +1 more source

Introduction to PANLAR guidelines: Takayasu's arteritis

open access: yesGlobal Rheumatology, 2022
Dr. Emilia Sato speaks about the process to achieve these guidelines and the benefits and impacts expected for the healthcare systems in the region.
Estefania Fajardo , Emilia
doaj   +1 more source

Takayasu's Arteritis in a Patient with Crohn's Disease: An Unexpected Association during Infliximab Therapy [PDF]

open access: yes, 2010
We report a 20-year-old woman with Crohn's disease (CD) who developed anterior neck pain while being treated with the anti-tumor necrosis factor (TNF)-alpha monoclonal antibody, infliximab.
Akamatsu, Taiji   +6 more
core   +1 more source

Manejo de arteritis de células gigantes en Argentina

open access: yesRevista Argentina de Reumatología, 2018
Introducción: hasta ahora el diagnóstico de la Arteritis de Células Gigantes (ACG) se ha basado fundamentalmente en la clínica y la biopsia de arteria temporal y el tratamiento en corticoides. En los últimos años, han aparecido nuevos métodos que ayudan
Marina Scolnik   +3 more
doaj   +1 more source

Cardiogenic shock from acute myocardial infarction induced by large-vessel Arteritis

open access: yesHeart and Mind, 2018
Coronary artery involvement in large-vessel arteritis is not uncommon, but rarely fatal. Here, we present a case of a young female with arteritis who was admitted to our hospital with acute myocardial infarction-induced cardiogenic shock.
Yanping Liu, Panpan Hao
doaj   +1 more source

Spontaneous remission of giant cell arteritis: possible association with a preceding acute respiratory infection and seropositivity to Chlamydia pneumoniae antibodies [PDF]

open access: yes, 2019
2019-02Recent epidemiological or immunopathological studies demonstrate the possible association between giant cell arteritis and infectious agents including Chlamydia pneumoniae.
Iwadate, Tomonobu   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy